The anti-tumor role and mechanism of integrated and truncated PDCD5 proteins in osteosarcoma cells

Cellular Signalling

Volumn 24, Issue 8, 2012, Pages 1713-1721

  Han, Xiao Rui ^a   Sun, Yu ^a   Bai, Xi Zhuang ^a  

^a the First Affiliated Hospital of China Medical University   (China)

Author keywords

Apoptosis; Cell signaling; G2 phase arrest; Osteosarcoma cell; PDCD5

Indexed keywords

CASPASE 3; CASPASE 9; CYCLIN B; CYCLIN DEPENDENT KINASE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROGRAMMED CELL DEATH 5 PROTEIN; RAF PROTEIN; RAS PROTEIN; SORAFENIB; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROGRAMMED CELL DEATH 5 GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS REGULATORY PROTEINS; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEOPLASM PROTEINS; NIACINAMIDE; OSTEOSARCOMA; PHENYLUREA COMPOUNDS; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

MUS;

EID: 84861580228     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.04.011     Document Type: Article

References (44)

1. Thompson R.C., Cheng E.Y., Clohisy D.R., Perentesis J., Manivel C., Le C.T. Clinical Orthopaedics and Related Research 2002, 397:240-347.
2. Arndt C.A., Crist W.M. The New England Journal of Medicine 1999, 341:342-352.
3. Wada T., Isu K., Takeda N., Usui M., Ishii S., Yamawaki S. Oncology 1996, 53:221-227.
4. Johnstone R.W., Ruefli A.A., Lowe S.W. Cell 2002, 108:153-164.
5. Waxman D.J., Schwartz P.S. Cancer Research 2003, 63:8563-8572.
6. Miyake H., Hara I., Hara S., Arakawa S., Kamidono S. Urology 2000, 56:332-336.
7. Tuve S., Racek T., Niemetz A., Schultz J., Soengas M.S., Putzer B.M. Apoptosis 2006, 11:235-243.
8. Okumura K., Nakase M., Nakamura S., Kamei T., Inui M., Tagawa T. Oncology Reports 2007, 17:769-773.
9. Ruan G.R., Zhao H.S., Chang Y., Li J.L., Qin Y.Z., Liu Y.R., Chen S.S., Huang X.J. Apoptosis 2008, 13:641-648.
10. Spinola M., Meyer P., Kammerer S., Falvella F.S., Boettger M.B., Hoyal C.R., Pignatiello C., Fischer R., Roth R.B., Pastorino U., Haeussinger K., Nelson M.R., Dierkesmann R., Dragani T.A., Braun A. Journal of Clinical Oncology 2006, 24:1672-1678.
11. Liu D., Feng Y., Cheng Y., Wang J. Biochemical and Biophysical Research Communications 2004, 318:391-396.
12. Liu H., Wang Y., Zhang Y., Song Q., Di C., Chen G., Tang J., Ma D. Biochemical and Biophysical Research Communications 1999, 254:203-210.
13. Chen Y., Sun R., Han W., Zhang Y., Song Q., Di C., Ma D. FEBS Letters 2001, 509:191-196.
14. Yang Y.H., Zhao M., Li W.M., Lu Y.Y., Chen Y.Y., Kang B., Lu Y.Y. Apoptosis 2006, 11:993-1001.
15. Rui M., Chen Y., Zhang Y., Ma D. Life Sciences 2002, 71:1771-1778.
16. Xu X.R., Huang J., Xu Z.G., Qian B.Z., Zhu Z.D., Yan Q., Cai T., Zhang X., Xiao H.S., Qu J., Liu F., Huang Q.H., Cheng Z.H., Li N.G., Du J.J., Hu W., Shen K.T., Lu G., Fu G., Zhong M., Xu S.H., Gu W.Y., Huang W., Zhao X.T., Hu G.X., Gu J.R., Chen Z., Han Z.G. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:15089-15094.
17. Zucchi I., Mento E., Kuznetsov V.A., Scotti M., Valsecchi V., Simionati B., Vicinanza E., Valle G., Pilotti S., Reinbold R., Vezzoni P., Albertini A., Dulbecco R. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:18147-18152.
18. Liu Z.H., Zhang D., Li K.M., Liao Q.P. Beijing Da Xue Xue Bao 2004, 36:407-410.
19. Li H., Wang Q., Gao F., Zhu F., Wang X., Zhou C., Liu C., Chen Y., Ma C., Sun W., Zhang L. Oncology Reports 2008, 20:573-579.
20. Ruan G.R., Qin Y.Z., Chen S.S., Li J.L., Ma X., Chang Y., Wang Y.Z., Fu J.Y., Liu Y.R. Leukemia Research 2006, 30:1159-1165.
21. Ma X., Ruan G., Wang Y., Li Q., Zhu P., Qin Y.Z., Li J.L., Liu Y.R., Ma D., Zhao H. Clinical Cancer Research 2005, 11:8592-8599.
22. Ray R.M., Zimmerman B.J., McCormack S.A., Patel T.B., Johnson L.R. American Journal of Physiology 1999, 276:C684-C691.
23. Rivard N., Boucher M.J., Asselin C., L'Allemain G. American Journal of Physiology 1999, 277:C652-C664.
24. Kaiser G.C., Yan F., Polk D.B. Experimental Cell Research 1999, 249:349-358.
25. Celano P., Berchtold C.M., Mabry M., Carroll M., Sidransky D., Casero R.A., Lupu R. Cell Growth & Differentiation 1993, 4:341-347.
26. Slack-Davis J.K., Eblen S.T., Zecevic M., Boerner S.A., Tarcsafalvi A., Diaz H.B., Marshall M.S., Weber M.J., Parsons J.T., Catling A.D. The Journal of Cell Biology 2003, 162:281-291.
27. Torii S., Nakayama K., Yamamoto T., Nishida E. Journal of Biochemistry 2004, 136:557-561.
28. Shapiro P. Critical Reviews in Clinical Laboratory Sciences 2002, 39:285-330.
29. Sivaraman V.S., Wang H., Nuovo G.J., Malbon C.C. The Journal of Clinical Investigation 1997, 99:1478-1483.
30. Oka H., Chatani Y., Hoshino R., Ogawa O., Kakehi Y., Terachi T., Okada Y., Kawaichi M., Kohno M., Yoshida O. Cancer Research 1995, 55:4182-4187.
31. Lin A.W., Barradas M., Stone J.C., van Aelst L., Serrano M., Lowe S.W. Genes & Development 1998, 12:3008-3019.
32. Wilhelm S.M., Carter C., Tang L., Wilkie D., McNabola A., Rong H., Chen C., Zhang X., Vincent P., McHugh M., Cao Y., Shujath J., Gawlak S., Eveleigh D., Liu B., Rowley L., Adnane L., Lynch M., Auclair D., Taylor I., Gedrich R., Voznesensky A., Riedl B., Post L.E., Bollag G., Trail P.A. Cancer Research 2004, 64:7099-7109.
33. Alessandria G., Filippeschi S., Sinibaldi P., Mornet F., Passera P., Spreafico F., Cappa P.M., Gullino P.M. Cancer Research 1987, 47:4243-4247.
34. Caswell P.T., Vadrevu S., Norman J.C. Nature Reviews Molecular Cell Biology 2009, 10:843-853.
35. Chen L.N., Wang Y., Ma D.L., Chen Y.Y. Apoptosis 2006, 11:101-111.
36. Zezula J., Sexl V., Hutter C., Karel A., Schütz W., Freissmuth M. Journal of Biological Chemistry 1997, 272:29967-29974.
37. Das D., Pintucci G., Stern A. FEBS Letters 2000, 472:50-52.
38. Sewing A., Wiseman B., Lloyd A.C., Land H. Molecular and Cellular Biology 1997, 17:5588-5597.
39. Zurlo D., Leone C., Assante G., Salzano S., Renzone G., Scaloni A., Foresta C., Colantuoni V., Lupo A. Molecular Carcinogenesis Oct 24 2011, [Epub ahead of print].
40. Huang S.Y., Hsieh M.J., Chen C.Y., Chen Y.J., Chen J.Y., Chen M.R., Tsai C.H., Lin S.F., Hsu T.Y. Journal of General Virology Sep 14 2011, 93(Pt 1):139-149. (Electronic publication ahead of print).
41. Sakai K., Barnitz R.A., Chaigne-Delalande B., Bidère N., Lenardo M.J. Virology Journal 2011, 8:219.
42. Chen C., Zhou H., Xu L., Xu D., Wang Y., Zhang Y., Liu X., Liu Z., Ma D., Ma Q., Chen Y. Apoptosis 2010, 15:805-813.
43. Gorlick R., Anderson P., Andrulis I., Arndt C., Beardsley G.P., Bernstein M., Bridge J., Cheung N.K., Dome J.S., Ebb D., Gardner T., Gebhardt M., Grier H., Hansen M., Healey J., Helman L., Hock J., Houghton J., Houghton P., Huvos A., Khanna C., Kieran M., Kleinerman E., Ladanyi M., Lau C., Malkin D., Marina N., Meltzer P., Meyers P., Schofield D., et al. Clinical Cancer Research 2003, 9:5442-5453.
44. Siegel H.J., Pressey J.G. Expert Review of Anticancer Therapy 2008, 8:1257-1269.